Related Experiment Video
Updated: Jan 23, 2026

Analyzing Mixing Inhomogeneity in a Microfluidic Device by Microscale Schlieren Technique
Published on: June 12, 2015
A Multiwell Microfluidic Device for Analyzing and Screening Nonhormonal Contraceptive Agents.
Hui Li1, Tyler Garner2, Francisco Diaz2
1Department of Biomedical Engineering, The Pennsylvania State University, 517 CBEB Building, University Park, PA, 16802, USA.
A new microfluidic device screens novel contraceptive agents by analyzing their effects on egg cell maturation. This technology aids in developing safer, more effective birth control methods, reducing side effects and improving family planning outcomes.
Area of Science:
- Reproductive biology
- Biomedical engineering
- Drug discovery
Background:
- Current contraceptives have limitations and side effects.
- Novel contraceptive development is crucial for public health.
- Targeting reproductive processes requires advanced screening tools.
Purpose of the Study:
- To develop a scalable microfluidic device for analyzing contraceptive agents.
- To screen the effects of potential agents on cumulus-oocyte complex maturation.
- To provide a platform for advancing birth control research.
Main Methods:
- A microfluidic device was designed for on-chip incubation and analysis of oocyte maturation and cumulus expansion.
- Oil-water interfaces isolated microwells to prevent crosstalk.
- Integrated filter membranes facilitated incubation, medium exchange, washing, and staining.
- Device performance was validated using drugs known to inhibit oocyte maturation and cumulus expansion.
Main Results:
- The microfluidic device successfully enabled on-chip monitoring of cumulus expansion and oocyte maturation.
- The device allowed for efficient sample handling, including washing and fluorescence staining.
- The screening platform demonstrated its utility in evaluating the impact of tested drugs on reproductive processes.
Conclusions:
- The developed microfluidic device offers a scalable and efficient platform for screening novel contraceptive agents.
- This technology can accelerate the development of new birth control methods with potentially fewer side effects.
- The device contributes to advancements in reproductive health and family planning research.
Related Concept Videos
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Mnemonic Devices
Acronyms
Acronyms are created by using the initial letters of a series of words to form a new word or phrase. This approach condenses complex information into a single, memorable entity. For example,...
Non-ohmic Devices
Consider a simple circuit consisting of a battery, a diode, and a resistor. A...
Oral Hypoglycemic Agents: Glinides

